NCT04730609View on ClinicalTrials.gov

Dexmedetomidine for Intraoperative Shivering in Scheduled Elective Cesarean Delivery

PHASE4RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 21, 2021

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
ShiveringDose Finding Study
Interventions
DRUG

Dexmedetomidine

Doses of dexmedetomidine will be selected according to a sequential up-and-down method, using a biased coin design to find the estimated dose at which 90% of patients would have desired effect

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04730609 - Dexmedetomidine for Intraoperative Shivering in Scheduled Elective Cesarean Delivery | Biotech Hunter | Biotech Hunter